KANSAS CITY, Mo., Feb. 12 An investor group in TrinityBiotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer ofdiagnostic products, is delighted that Jim Merselis has joined the company'sboard of directors. In addition to expressing support for Mr. Merselis, thegroup has scheduled a conference call regarding important shareholderdevelopments for 12:00 pm ET (9:00 am PT) on Tuesday, February 17, 2009.
All those interested in participating in the call should dial 888 300 5688and reference Conference ID 85881585.
Commenting on the news, Mr. Reidy stated, "We are pleased Jim has agreedto serve, bringing the total of independent directors to two. While Jim'sagreement to join as part of our broader effort is honorable, we continue ourcall to action for true board oversight and management accountability. Welook forward to Jim remaining as part of our new board immediately followingthe pending action to remove and replace the current board."
Commenting on the campaign and pending conference call, Mr. Reidy stated,"Much progress has been made that we look forward to sharing with our fellowshareholders, and we remain committed to our goals to effect the changesneeded to unlock shareholder value and provide the level of transparency wehave continued to advocate."
Tom Reidy, 816-260-8476, email@example.com
SOURCE KC Investor Group